Sidoti Downgrades USANA Health Sciences (USNA) to Neutral
More News related to USNA
- USANA General Counsel James Bramble Receives ACC Corporate Counsel Leadership Award
- USANA Health Sciences Announces New Vice President of Finance
- Goldman Sachs Downgrades Usana Health (USNA) to Sell
- USANA Health Sciences (USNA) Misses Q3 EPS Target; Guides FY08 EPS Below View
- Trading Radar for 10/14: Intel (INTC), Johnson & Johnson (JNJ), Pepsi (PEP), CSX (CSX), Genentech (DNA) Report;
More News related to Downgrades
- ARGUS Downgrades Smith International (SII) to Hold
- Cantor Fitzgerald Downgrades Audiocodes (AUDC) to Hold After Negative 4Q Preannouncement
- MDB Capital Downgrades Ener1 (HEV) to Sell, Suspends Earnings Model and Valuation on Stock No Longer Justified
- DA Davidson Downgrades Ambassadors Group (EPAX) to Neutral
- SunTrust Downgrades Ruby Tuesday, Inc. (RT) to Neutral
Sidoti & Co. downgrades USANA Health Sciences (Nasdaq: USNA) from Buy to Neutral.
USANA Health Sciences, Inc. develops, manufactures, and distributes nutritional and personal care products.
Related Categories
DowngradesStocks Mentioned
+0.36Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
